WarfaRisk
Dr. Areej Al-Wabil

Dr. Areej Al-Wabil

Project lead, WarfaRisk

Dr. Areej Al-Wabil is one of the three project leads of WarfaRisk, an open research project on warfarin dose prediction.

Also written: Areej Alwabil.

About WarfaRisk

WarfaRisk is an open research project that predicts a weekly warfarin dose with a 90% range around it, then checks how well that range held up for each ancestry group. It is a research prototype, not tested in patients and not for clinical use.

The project is described in two peer-reviewed papers from 2026. The code and trained models are open.

Links

The rest of the team

Research prototype. Not tested in patients and not for clinical use. The dose and range shown by WarfaRisk must not be used to make dosing decisions.